Interview 12 Jun 2017
This Italian Academic-turned-CEO also Launched 7 Cancer Drugs at GSK
…cancer and on gene therapy, cell therapy and oncolytic viruses. What was it about GammaDelta’s technology that convinced you to join the company? The possibility to transform the treatment of…